Skip to main content
. 2025 Sep 15;26(18):8969. doi: 10.3390/ijms26188969
APS-1 Autoimmune Polyendocrine Syndrome Type 1
APECED Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy
AIRE Autoimmune Regulator
CMC Chronic Mucocutaneous Candidiasis
SCC Squamous Cell Carcinoma
HNSCC Head and Neck Squamous Cell Carcinoma
IL Interleukin
IFN Interferon
EGFR Epidermal Growth Factor Receptor
MAPK Mitogen-Activated Protein Kinase
NF-κB Nuclear Factor Kappa-light-chain-enhancer of activated B cells
STAT3 Signal Transducer and Activator of Transcription 3
TP53 Tumor Protein p53
CDKN2A Cyclin Dependent Kinase Inhibitor 2A (p16INK4a)
PICOS Population, Intervention, Comparator, Outcome, Study Design
PRISMA-ScR Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Re-views
ROB Risk of Bias
ROS Reactive Oxygen Species
RNS Reactive Nitrogen Species
OLP Oral Lichen Planus
SEER Surveillance, Epidemiology, and End Results Program